Limited coverage drugs – alendronate

Generic name

alendronate, including in combination with cholecalciferol (vitamin D3)


10 mg, 70 mg, 70 mg/5600 IU



Special Authority criteria

Approval period

Clinical or radiographically documented fracture due to osteoporosis.


Glucocorticoid-induced osteoporosis in patients who are receiving or expected to receive the equivalent dose of 7.5 mg of prednisone per day or greater AND for 90 consecutive days or longer.




1 year

Practitioner exemptions

  • None

Special notes

  • Patients who meet the above criteria for osteoporosis for alendronate automatically receive coverage for both alendronate and risedronate
  • Clinical fracture is defined as a symptomatic (painful) fracture
  • Radiographically documented fracture is defined as a fracture identified by x-ray (e.g., vertebral compression fracture). This may be asymptomatic
  • Coverage is intended for patients taking glucocorticoids with significant systemic absorption only (e.g., by oral or parenteral routes)

Special Authority request form(s)